Treacy Paul 4
4 · Jazz Pharmaceuticals plc · Filed Mar 4, 2019
Insider Transaction Report
Form 4
Treacy Paul
SVP, Technical Operations
Transactions
- Award
Ordinary Shares
2019-02-28+5,000→ 22,583 total - Sale
Ordinary Shares
2019-03-01$139.50/sh−351$48,965→ 21,709 total - Award
Non-Qualified Stock Option (right to buy)
2019-02-28+12,500→ 12,500 totalExercise: $140.03Exp: 2029-02-27→ Ordinary Shares (12,500 underlying) - Sale
Ordinary Shares
2019-03-01$139.50/sh−523$72,959→ 22,060 total
Footnotes (4)
- [F1]These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2019, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years.
- [F2]Includes 125 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on November 30, 2018.
- [F3]Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
- [F4]These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, February 28, 2019, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter.